United States · FDA National Drug Code directory
Stribild
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 61958-1201_65c2d2eb-d180-41c3-b346-9cdc6e52d5ed
- Product NDC
- 61958-1201
- Form
- TABLET, FILM COATED
- Composition / generic term
- elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate
- Labeler
- Gilead Sciences, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20120827
- Source listing expiry
- 20261231
Source-listed ingredients
- ELVITEGRAVIR — 150 mg/1
- COBICISTAT — 150 mg/1
- EMTRICITABINE — 200 mg/1
- TENOFOVIR DISOPROXIL FUMARATE — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (61958-1201-1) · 61958-1201-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →